APA (7th ed.) Citation

J, T., J, Z., H, E., L, P., J, K., SH, D., . . . Y, G. (2026). Loss of cystathionine-β-synthase contributes to elevated OXPHOS, a vulnerability in Ara-C-resistant Myeloid Leukemia in Down syndrome. Biochemical pharmacology, 247, 117815. https://doi.org/10.1016/j.bcp.2026.117815

Chicago Style (17th ed.) Citation

J, Thibodeau, et al. "Loss of Cystathionine-β-synthase Contributes to Elevated OXPHOS, a Vulnerability in Ara-C-resistant Myeloid Leukemia in Down Syndrome." Biochemical Pharmacology 247 (2026): 117815. https://doi.org/10.1016/j.bcp.2026.117815.

MLA (9th ed.) Citation

J, Thibodeau, et al. "Loss of Cystathionine-β-synthase Contributes to Elevated OXPHOS, a Vulnerability in Ara-C-resistant Myeloid Leukemia in Down Syndrome." Biochemical Pharmacology, vol. 247, 2026, p. 117815, https://doi.org/10.1016/j.bcp.2026.117815.